Astria Therapeutics, Inc. announced that it has named Chris Morabito, M.D., as Chief Medical Officer. Dr. Morabito brings more than 20 years of clinical development experience in rare diseases and other indications to Astria. Dr. Morabito most recently served as the Chief Medical Officer at Fulcrum Therapeutics.

Prior to that, he was the Chief Medical Officer at Cardurion Pharmaceuticals. Dr. Morabito has also held senior R&D positions at Takeda, Sanofi, and Merck. Dr. Morabito trained at Stanford University and the University of California, San Francisco after receiving his M.D. from Penn State University College of Medicine.